Jeremy Howe

Jeremy Howe is a seasoned professional in the biopharmaceutical manufacturing sector, currently serving as a Sr. Manufacturing Manager at AGC Biologics since August 2021 and as a Manufacturing Manager at Novartis Gene Therapies since April 2019. With a robust background that includes key roles at AstraZeneca and MedImmune/AstraZeneca, Jeremy has extensive experience in supervising and managing upstream manufacturing operations from facility start-up through commercial production. A former Production Manager at Amgen, Jeremy coordinated operations within a multibillion-dollar drug company, and started their career at PR Pharmaceuticals, where Jeremy manufactured sterile injectables. Jeremy holds a Bachelor of Science in Public Health Education and Promotion from Liberty University.